Ligand ID: CU9 Drugbank ID: DB01336(Metocurine) Indication:Metocurine is a muscle relaxant. |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 1ssk | NUCLEOCAPSID PROTEIN (SARSr-CoV) | 4 / 6 | THR A 54GLN A 138ILE A 52SER A 56 | 1.68A | 20.09 | None | ||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 2dd8 | IGG LIGHT CHAIN (Homosapiens) | 4 / 6 | GLN L 37TYR L 86GLN L 7ILE L 21 | 1.47A | 23.48 | None | ||
![]() | 3PEO_F_CU9F301_1 (SOLUBLEACETYLCHOLINERECEPTOR) | 2ga6 | ORF1A POLYPROTEIN (SARSr-CoV) | 4 / 7 | TYR S 27TYR S 76CYH S 90CYH S 77 | 1.63A | 20.09 | NoneNone ZN S 998 (-2.2A) ZN S 998 (-1.9A) | ||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 2q6g | REPLICASEPOLYPROTEIN 1AB (SARS-COVBJ01) | 4 / 6 | THR A 292GLN A 127GLN A 110ILE A 106 | 1.53A | 22.88 | None | ||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 2xyq | PUTATIVE 2'-O-METHYLTRANSFERASE (SARSr-CoV) | 4 / 6 | THR A 48GLN A 49ILE A 40SER A 243 | 1.70A | 21.15 | None | ||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 2xyr | PUTATIVE 2'-O-METHYLTRANSFERASE (SARSr-CoV) | 4 / 6 | THR A 48GLN A 49ILE A 40SER A 243 | 1.69A | 20.83 | None | ||
![]() | 3PEO_A_CU9A301_1 (SOLUBLEACETYLCHOLINERECEPTOR) | 2xyr | NSP10 (SARSr-CoV) | 5 / 12 | VAL B 42ILE B 99TYR B 27TYR B 76CYH B 90 | 1.72A | 20.64 | NoneNoneNoneNone ZN B1132 (-2.4A) | ||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 3bgf | F26G19 FABSPIKE PROTEIN S1 (Musmusculus;SARSr-CoV) | 4 / 6 | THR H 31TYR H 52ILE S 489SER S 362 | 1.54A | 24.60 | None | ||
![]() | 3PEO_A_CU9A301_1 (SOLUBLEACETYLCHOLINERECEPTOR) | 3bgf | F26G19 FABSPIKE PROTEIN S1 (Musmusculus;SARSr-CoV) | 5 / 12 | GLN C 27ILE C 2SER C 30TYR C 91TYR A 491 | 1.72A | 23.29 | None | ||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 3e91 | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 6 | THR A 292GLN A 127GLN A 110ILE A 106 | 1.64A | 20.45 | None | ||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 3f9h | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 6 | THR B 292GLN B 127GLN B 110ILE B 106 | 1.71A | 20.45 | None | ||
![]() | 3PEO_D_CU9D301_1 (SOLUBLEACETYLCHOLINERECEPTOR) | 3i6g | HLA, A-2 (Homosapiens) | 5 / 10 | TYR D 7TYR D 59THR D 163TYR D 159GLN A 155 | 1.50A | 20.86 | None | ||
![]() | 3PEO_J_CU9J301_1 (SOLUBLEACETYLCHOLINERECEPTOR) | 3i6g | HLA, A-2 (Homosapiens) | 5 / 11 | TYR A 7TYR A 59THR A 163TYR A 159GLN D 155 | 1.53A | 20.86 | None | ||
![]() | 3PEO_B_CU9B301_1 (SOLUBLEACETYLCHOLINERECEPTOR) | 3i6g | HLA, A-2 (Homosapiens) | 5 / 12 | TYR A 7TYR A 59THR A 163TYR A 159GLN D 155 | 1.59A | 20.86 | None | ||
![]() | 3PEO_J_CU9J301_1 (SOLUBLEACETYLCHOLINERECEPTOR) | 3i6l | HLA, A-24NUCLEOPROTEINPEPTIDE (Homosapiens;SARSr-CoV) | 5 / 11 | TYR D 123TRP D 147TYR D 116ILE F 7SER D 11 | 1.73A | 21.24 | None | ||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 3i6l | HLA, A-24NUCLEOPROTEINPEPTIDE (Homosapiens;SARSr-CoV) | 4 / 6 | TYR D 116GLN D 156ILE F 7SER D 9 | 1.47A | 21.24 | None | ||
![]() | 3PEO_B_CU9B301_1 (SOLUBLEACETYLCHOLINERECEPTOR) | 3iwm | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | TYR B 161CYH B 128TYR B 118GLN C 299SER B 147 | 1.75A | 20.45 | None | ||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 3iwm | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 6 | THR C 292GLN A 127GLN A 110ILE A 106 | 1.59A | 20.45 | None | ||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 3m3s | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 6 | THR A 292GLN A 127GLN A 110ILE A 106 | 1.67A | 20.45 | None | ||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 3r24 | 2'-O-METHYLTRANSFERASE (SARSr-CoV) | 4 / 6 | THR A 48GLN A 49ILE A 40SER A 243 | 1.70A | 20.57 | None | ||
![]() | 3PEO_B_CU9B301_1 (SOLUBLEACETYLCHOLINERECEPTOR) | 3scl | ACE2SPIKE GLYCOPROTEIN (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | LYS A 353TYR E 481THR E 425GLN E 492TYR E 494 | 1.64A | 16.18 | None | ||
![]() | 3PEO_F_CU9F301_1 (SOLUBLEACETYLCHOLINERECEPTOR) | 3to2 | MD3-C9 PEPTIDEDERIVED FROMMEMBRANEGLYCOPROTEINMHC CLASS I ANTIGEN (Homosapiens;SARS-COVTJF) | 4 / 7 | TYR A 116TRP A 147TYR A 99CYH C 3 | 1.79A | 20.86 | None | ||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 5c5o | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 6 | THR A 292GLN A 127GLN A 110ILE A 106 | 1.63A | 20.45 | None | ||
![]() | 3PEO_B_CU9B301_1 (SOLUBLEACETYLCHOLINERECEPTOR) | 5e6j | REPLICASEPOLYPROTEIN 1ABUBIQUITIN (SARSr-CoV;syntheticconstruct) | 5 / 12 | TYR A 269TYR A 274CYH A 112TYR A 265GLN B 40 | 1.79A | 20.24 | NoneNoneAYE B 76 ( 1.6A)NoneNone | ||
![]() | 3PEO_F_CU9F301_1 (SOLUBLEACETYLCHOLINERECEPTOR) | 5e6j | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 4 / 7 | TYR D 269TYR D 274CYH D 112TYR D 265 | 1.47A | 20.24 | NoneNoneAYE E 76 (-1.6A)None | ||
![]() | 3PEO_F_CU9F301_1 (SOLUBLEACETYLCHOLINERECEPTOR) | 5nfy | POLYPROTEIN 1AB (SARS-COVFrankfurt1) | 4 / 7 | TYR A 447LYS A 318CYH A 484CYH A 452 | 1.64A | 16.28 | NoneNone ZN A 603 (-2.5A) ZN A 603 (-2.6A) | ||
![]() | 3PEO_F_CU9F301_1 (SOLUBLEACETYLCHOLINERECEPTOR) | 5tl6 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 4 / 7 | TYR B 269TYR B 274CYH B 112TYR B 265 | 1.41A | 22.40 | NoneNoneAYE A 157 ( 1.6A)None | ||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 5x5b | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 4 / 6 | THR B1087GLN B1088ILE B 694SER B1093 | 1.69A | 11.10 | None | ||
![]() | 3PEO_B_CU9B301_1 (SOLUBLEACETYLCHOLINERECEPTOR) | 5x5f | S PROTEIN (MERS-CoV) | 5 / 12 | TYR B 71THR A 579GLN A 636TYR A 632GLN A 628 | 1.78A | 10.50 | None | ||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 5x5f | S PROTEIN (MERS-CoV) | 4 / 6 | THR B 574GLN B 471ILE B 428SER B 472 | 1.39A | 10.50 | None | ||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 5xlr | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 6 | GLN C 895TYR C 886GLN C 883ILE C 878 | 1.56A | 10.90 | GLN C 895 ( 0.6A)TYR C 886 ( 1.3A)GLN C 883 ( 0.6A)ILE C 878 ( 0.6A) | ||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 5zvm | PAN-COV INHIBITORYPEPTIDE EK1SPIKE GLYCOPROTEIN (SARSr-CoV;syntheticconstruct) | 4 / 6 | GLN C 917TYR c 36GLN A 904ILE c 37 | 1.69A | 16.97 | None | ||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6acg | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 6 | THR A 921GLN A 786ILE A 800SER A 919 | 1.42A | 10.90 | None | ||
![]() | 3PEO_J_CU9J301_1 (SOLUBLEACETYLCHOLINERECEPTOR) | 6crw | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 11 | TYR B 819LYS B 818GLN B 835ILE B 832SER A 574 | 1.62A | 10.98 | None | ||
![]() | 3PEO_A_CU9A301_1 (SOLUBLEACETYLCHOLINERECEPTOR) | 6crz | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | GLN C 396VAL C 496ILE C 405TYR C 338TYR C 481 | 1.74A | 10.98 | None | ||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6cs1 | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 4 / 6 | THR A 991GLN C 992GLN A 993ILE A 752 | 1.66A | 10.98 | None | ||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6jyt | HELICASE (SARSr-CoV) | 4 / 6 | THR A 552GLN A 548ILE A 480SER A 555 | 1.69A | 17.38 | None | ||
![]() | 3PEO_J_CU9J301_1 (SOLUBLEACETYLCHOLINERECEPTOR) | 6lzg | ACE2SPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 11 | TYR B 505LYS A 353GLN B 506ILE B 402SER B 443 | 1.79A | 22.80 | None | ||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6m0j | SPIKE RECEPTORBINDING DOMAIN (SARS-CoV-2) | 4 / 6 | GLN E 493TYR E 453GLN E 409ILE E 418 | 1.56A | 22.80 | None | ||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6m0j | ACE2 (Homosapiens) | 4 / 6 | THR A 20GLN A 24GLN A 89ILE A 88 | 1.69A | 17.01 | None | ||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6m18 | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 4 / 6 | THR C 559TYR C 560GLN C 574ILE C 562 | 1.54A | 17.02 | None | ||
![]() | 3PEO_B_CU9B301_1 (SOLUBLEACETYLCHOLINERECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | TYR C 161CYH C 128TYR C 118GLN A 299SER C 147 | 1.78A | 22.56 | None | ||
![]() | 3PEO_B_CU9B301_1 (SOLUBLEACETYLCHOLINERECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | TYR B 161CYH B 128TYR B 118GLN D 299SER B 147 | 1.76A | 22.56 | None | ||
![]() | 3PEO_B_CU9B301_1 (SOLUBLEACETYLCHOLINERECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | TYR D 161CYH D 128TYR D 118GLN B 299SER D 147 | 1.79A | 22.56 | None | ||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 6 | THR D 292GLN D 127GLN D 110ILE D 106 | 1.77A | 22.56 | None | ||
![]() | 3PEO_B_CU9B301_1 (SOLUBLEACETYLCHOLINERECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | TYR A 161CYH A 128TYR A 118GLN C 299SER A 147 | 1.78A | 22.56 | None | ||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 6 | THR A 292GLN A 127GLN A 110ILE A 106 | 1.78A | 22.56 | None | ||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6nb6 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 6 | THR B 894GLN B1095GLN B 895SER B1093 | 1.69A | 10.68 | None | ||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6nb8 | S230 ANTIGEN-BINDING(FAB) FRAGMENT,LIGHT CHAIN (Homosapiens) | 4 / 6 | GLN L 42TYR L 91GLN L 6ILE L 21 | 1.43A | 22.03 | None | ||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6nus | NSP12 (SARSr-CoV) | 4 / 6 | THR A 531TYR A 530GLN A 661ILE A 536 | 1.70A | 13.10 | None | ||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 6 | THR B 874GLN B1054GLN B 872SER B1055 | 1.12A | 10.91 | None | ||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6vw1 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 6 | GLN F 493TYR F 453GLN F 409ILE F 418 | 1.66A | 19.50 | None | ||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 6 | THR C 874GLN C1054GLN C 872SER C1055 | 1.18A | 11.08 | None | ||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 6 | THR B 874GLN B1054GLN B 872SER B1055 | 1.22A | 11.32 | None | ||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6w41 | CR3022 FAB HEAVYCHAIN (Homosapiens) | 4 / 6 | THR H 68GLN H 64TYR H 59ILE H 51 | 1.62A | 21.78 | None | ||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6w41 | CR3022 FAB HEAVYCHAINCR3022 FAB LIGHTCHAIN (Homosapiens) | 4 / 6 | THR L 94GLN L 89TYR L 96ILE H 98 | 1.80A | 22.88 | None | ||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6w41 | SPIKE PROTEIN S1 (SARS-CoV-2) | 4 / 6 | GLN C 493TYR C 453GLN C 409ILE C 418 | 1.67A | 19.31 | None | ||
![]() | 3PEO_J_CU9J301_1 (SOLUBLEACETYLCHOLINERECEPTOR) | 6w41 | CR3022 FAB HEAVYCHAINCR3022 FAB LIGHTCHAIN (Homosapiens) | 5 / 11 | TYR L 96GLN L 3ILE L 2SER H 62SER H 60 | 1.59A | 22.88 | None | ||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6w41 | CR3022 FAB LIGHTCHAIN (Homosapiens) | 4 / 6 | GLN L 37TYR L 86GLN L 6ILE L 21 | 1.41A | 22.88 | SO4 L 302 ( 4.8A)NoneNoneNone | ||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6w41 | SPIKE PROTEIN S1 (SARS-CoV-2) | 4 / 6 | GLN C 493TYR C 453ILE C 418SER C 494 | 1.72A | 19.31 | None | ||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 6 | THR A6846GLN A6847ILE A6838SER A7041 | 1.74A | None | |||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 6 | THR A6846GLN A6847ILE A6838SER A7041 | 1.73A | 20.87 | None | ||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 6 | THR C6846GLN C6847ILE C6838SER C7041 | 1.72A | 20.87 | None | ||
![]() | 3PEO_F_CU9F301_1 (SOLUBLEACETYLCHOLINERECEPTOR) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 7 | TRP C 106TYR B 273CYH B 111TYR B 264 | 1.37A | 23.46 | None | ||
![]() | 3PEO_F_CU9F301_1 (SOLUBLEACETYLCHOLINERECEPTOR) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 7 | TRP A 106TYR C 273CYH C 111TYR C 264 | 1.37A | 23.46 | None | ||
![]() | 3PEO_F_CU9F301_1 (SOLUBLEACETYLCHOLINERECEPTOR) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 7 | TRP B 106TYR A 273CYH A 111TYR A 264 | 1.51A | 23.46 | None | ||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 6 | THR A6846GLN A6847ILE A6838SER A7041 | 1.71A | None | |||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 6 | THR C6846GLN C6847ILE C6838SER C7041 | 1.75A | None | |||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 6 | THR C6846GLN C6847ILE C6838SER C7041 | 1.73A | None | |||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 6 | THR A6846GLN A6847ILE A6838SER A7041 | 1.72A | None | |||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 6 | THR A6846GLN A6847ILE A6838SER A7041 | 1.73A | None | |||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6yla | HEAVY CHAIN (Homosapiens) | 4 / 6 | THR H 69GLN H 65TYR H 60ILE H 51 | 1.63A | None | |||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6yla | LIGHT CHAIN (Homosapiens) | 4 / 6 | GLN C 43TYR C 92GLN C 6ILE C 21 | 1.42A | None | |||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6yla | LIGHT CHAIN (Homosapiens) | 4 / 6 | GLN L 43TYR L 92GLN L 6ILE L 21 | 1.41A | None | |||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 6 | GLN E 493TYR E 453GLN E 409ILE E 418 | 1.68A | MLI E 903 ( 4.0A)NoneNoneNone | |||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6yla | HEAVY CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 4 / 6 | THR B 31GLN B 1TYR A 369SER B 100 | 1.45A | None | |||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 6 | GLN A 493TYR A 453GLN A 409ILE A 418 | 1.68A | None | |||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6yla | HEAVY CHAIN (Homosapiens) | 4 / 6 | THR B 69GLN B 65TYR B 60ILE B 51 | 1.65A | None | |||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6yla | HEAVY CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 4 / 6 | THR H 31GLN H 1TYR E 369SER H 100 | 1.40A | None | |||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6ym0 | LIGHT CHAIN (Homosapiens) | 4 / 6 | GLN L 43TYR L 92GLN L 6ILE L 21 | 1.40A | None | |||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6ym0 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 6 | GLN E 493TYR E 453GLN E 409ILE E 418 | 1.63A | None | |||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6ym0 | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 4 / 6 | THR L 100GLN L 96TYR L 102ILE H 50 | 1.80A | None | |||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6ym0 | HEAVY CHAIN (Homosapiens) | 4 / 6 | THR H 69GLN H 65TYR H 60ILE H 51 | 1.64A | None | |||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 6 | GLN A 493TYR A 453GLN A 409ILE A 418 | 1.68A | None | |||
![]() | 3PEO_J_CU9J301_1 (SOLUBLEACETYLCHOLINERECEPTOR) | 6yor | IGG H CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 11 | GLN E 493TYR E 453GLN E 409ILE E 418SER B 17 | 1.76A | 19.92 | None | ||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6yor | IGG H CHAIN (Homosapiens) | 4 / 6 | THR B 69GLN B 65TYR B 60ILE B 51 | 1.62A | None | |||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6yor | IGG H CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 4 / 6 | TYR E 453GLN E 409ILE E 418SER B 17 | 1.72A | None | |||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6yor | IGG L CHAIN (Homosapiens) | 4 / 6 | GLN L 43TYR L 92GLN L 6ILE L 21 | 1.41A | None | |||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6yor | IGG H CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 4 / 6 | THR B 31GLN B 1TYR A 369SER B 100 | 1.40A | None | |||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6yor | IGG L CHAIN (Homosapiens) | 4 / 6 | GLN C 43TYR C 92GLN C 6ILE C 21 | 1.41A | None | |||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6yor | IGG H CHAIN (Homosapiens) | 4 / 6 | THR H 69GLN H 65TYR H 60ILE H 51 | 1.63A | None | |||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6yor | IGG H CHAINIGG L CHAIN (Homosapiens) | 4 / 6 | THR L 100GLN L 95TYR L 102ILE H 102 | 1.80A | None | |||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 6 | GLN E 493TYR E 453GLN E 409ILE E 418 | 1.68A | None | |||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 6yor | IGG H CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 4 / 6 | THR H 31GLN H 1TYR E 369SER H 100 | 1.40A | None | |||
![]() | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | 7buy | VIRUS MAIN PROTEASE (SARS-CoV-2) | 4 / 6 | THR A 111GLN A 110ILE A 106SER A 113 | 1.77A | NoneNoneNoneDMS A 406 ( 4.8A) |